[1] |
苟苗苗, 张勇, 司海燕, 等. 循环肿瘤细胞与中晚期结直肠癌临床特征及生存的关系[J]. 解放军医学院学报, 2019, 40(2):117-120.
|
[2] |
白东晓, 杨海军. 循环肿瘤细胞检测与结直肠癌复发转移的研究进展[J]. 中国肿瘤临床, 2017, 44(3):142-145.
|
[3] |
BIDARD F C, PEETERS D J, FEHM T, et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer:a pooled analysis of individual patient data[J]. Lancet Oncol, 2014, 15(4):406-414.
DOI
URL
|
[4] |
TIE J, KINDE I, WANG Y, et al. Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer[J]. Ann Oncol, 2015, 26(8):1715-1722.
DOI
URL
|
[5] |
SCHER H I, HELLER G, MOLINA A, et al. Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer[J]. J Clin Oncol, 2015, 33(12):1348-1355.
DOI
URL
|
[6] |
姚宏伟, 吴鸿伟, 刘荫华. 从传统“群体化”诊治到精准“个体化”医疗:AJCC第八版结直肠癌分期系统更新解读[J]. 中华外科杂志, 2017, 55(1):24-27.
|
[7] |
SOTELO M J, SASTRE J, MAESTRO M L, et al. Role of circulating tumor cells as prognostic marker in resected stage Ⅲ colorectal cancer[J]. Ann Oncol, 2015, 26(3):535-541.
DOI
URL
|
[8] |
ONSTENK W, SIEUWERTS A M, MOSTERT B, et al. Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer[J]. Oncotarget, 2016, 7(37):59058-59069.
DOI
URL
|
[9] |
MUSELLA V, PIETRANTONIO F, DI BUDUO E, et al. Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory,RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab[J]. Int J Cancer, 2015, 137(6):1467-1474.
DOI
URL
|
[10] |
ABDALLAH E A, FANELLI M F, BUIM M E, et al. Thymidylate synthase expression in circulating tumor cells:a new tool to predict 5-fluorouracil resistance in metastatic colorectal cancer patients[J]. Int J Cancer, 2015, 137(6):1397-1405.
DOI
URL
|
[11] |
WANG Y, LIU Y F, CHENG Y, et al. Prognosis of colorectal cancer with liver metastasis:value of a prognostic index[J]. Braz J Med Biol Res, 2010, 43(11):1l16-1122.
|
[12] |
曾艳, 张力, 贺帅. 结直肠癌患者血清CEA和CA19-9水平与肝转移的关系[J]. 癌症进展, 2019, 17(13):1586-1589.
|
[13] |
杨含腾, 罗长江, 杜鹏, 等. 糖类抗原125、癌胚抗原表达对T4期结直肠癌术后患者预后的影响及其临床意义[J]. 中华实验外科杂志, 2019, 36(8):1466-1468.
|
[14] |
JONES L A, FERRANS C E, POLITE B N, et al. Examining racial disparities in colon cancer clinical delay in the Colon Cancer Pattems of Care in Chicago Study[J]. Ann Epidemiol, 2017, 27(11):731-738.
DOI
URL
|
[15] |
尹婧婧, 周礼鲲, 李鸿立, 等. 循环肿瘤细胞与乳腺癌患者预后相关性的Meta 分析[J]. 中国肿瘤临床, 2012, 39(9):602-606.
|
[16] |
COHEN S J, PUNT C J, IANNOTTI N, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer[J]. Ann Oncol, 2009, 20(7):1223-1229.
DOI
URL
|